Landscapes / Companies
ARS Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 4 in all
Trials
2 active
5 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
On the market | Apr 2027Phase 4 trial completes | |||
| Next date | Apr 2027 · Phase 4 trial completes | ||||
| Also tested for | Allergic Reactions | ||||
| Open drug page | |||||
ARS-2not checked |
— |
Phase 2 | Jun 2027Phase 2 trial completes | ||
| Next date | Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Urticaria Chronic | ||||
| Open drug page | |||||
About
- No active trial
- Albuterol MDI, ARS-1 without URTI
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021